関連する実験動画

Updated: Jul 5, 2026

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

推定HIV-1プロテアゼに対応する合成99残留タンパク質の酵素活性

J Schneider¹, S B Kent

¹Division of Biology, California Institute of Technology, Pasadena 91125.

|July 29, 1988

まとめ

合成されたヒト免疫不全ウイルス1 (HIV-1) プロテアゼは,特定のタンパク質分解活性を示しています. このブレークスルーにより,獲得免疫不全症候群 (AIDS) に対する標的型抗ウイルス剤の開発が可能になりました.

科学分野:

バイオケミストリーバイオケミストリー
ウイルス学ウイルス学ウイルス学
ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー

背景:

ヒト免疫不全ウイルス1 (HIV-1) プロテアゼは,ウイルスの複製に不可欠です.
酵素活性を理解することは,抗ウイルス治療の開発の鍵です.
これまでの研究は,ウイルスライフサイクルにおけるプロテアゼの役割を理解することに焦点を当てていました.

研究の目的:

HIV-1 プロテアゼを化学的に合成するために.
タンパク質分解活動と基板特異性を特徴付けるため.
阻害剤設計のための定義された分子ツールを提供する.

主な方法:

99残留のHIV-1プロテアゼの全化学合成.
天然のガグ前駆体断片と合成ペプチド基板を使用して測定する.
酵素家族分類を決定するための阻害研究.

主要な成果:

合成HIV-1プロテアゼは,特定のタンパク質分解活性を示した.
典型的なPhe/Tyr-Pro債券を超えて,基質特異性が観察されました.
抑制研究は,HIV-1プロテアゼをアスパルティックプロテアゼとして確認した.

結論:

活性HIV-1プロテアゼの化学合成は達成可能である.
これは,特定の抗ウイルス性阻害剤の設計に不可欠なツールを提供します.
HIV-1プロテアゼをターゲットにすることは,エイズに対する有望な戦略です.

さらに関連する動画

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

関連する概念動画

Enzymes

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...